Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Dec 6 2022

Full Issue

Viewpoints: Children's Health Care Not A Priority; Vaccine Production Must Be More Widespread

Editorial writers weigh in on these public health issues.

Stat: Pediatricians And Parents On The Brink: This Is Their March 2020

In March 2020, as the Covid-19 pandemic swept across the United States, the nation’s pediatric providers and pediatric units immediately pitched in to treat adults sickened by this then-mysterious and deadly disease. But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, influenza, and respiratory syncytial virus (RSV), the response from outside this community has been slow. (Sallie Permar and Robert J. Vinci, 12/6)

The New York Times: Countries Need To Make Their Own Vaccines. Why Isn’t The U.S. Embracing This Pandemic Prevention Strategy?

To avoid a repeat of this tragedy, every region of the world must be able to make its own vaccines. Right now, Africa, Latin America and parts of Southeast Asia rely primarily on imported vaccines. (Amy Maxmen, 12/6)

Bloomberg: Who Dealt Best With COVID? The Data Are In.

Whose pandemic strategy really saved lives? Which states or countries lost the most people to the virus? Or to the unintended consequences of mitigation efforts? Now there's finally some clear, objective data emerging from the fog. (Faye Flam, 12/5)

Chicago Tribune: Hemsworth, Jolie Raise Awareness By Sharing Genetic Risks

By sharing his genetic test results, actor Chris Hemsworth is accelerating awareness and acceptance of proactive testing. (Robert C. Green, 12/5)

The CT Mirror: IUDs: An Imperfect Solution To An Impossible Problem

“The kind of pain that I experienced, for the length of time that I did… I would have ripped out my IUD with my teeth if I could have.” Holly Jameson*, a 23-year-old college-aged woman living in Rhode Island, was motivated to get an IUD (intrauterine device) – a method of birth control – as a way to prepare for an unpredictable future after the U.S. Supreme Court overruled Roe v. Wade. (Marley Belanger, 12/5)

Modern Healthcare: Community Health Centers Must Collaborate To Aid Diverse Populations 

Imagine you arrive in a new country and have a medical need, but you don’t speak the local language and don’t know how or where to find care. In recent weeks, thousands of migrants to the United States have found themselves in precisely that situation, after being transported from the southern border to communities across the country. (Linnea Windel, 12/6)

Stat: Modernize FDA's Ability To Regulate Diagnostic Tests, Cosmetics

Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. (Scott Gottlieb and Mark B. McClellan, 12/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF